The midlatency auditory evoked potential P50 is abnormal in Huntington's disease

Journal of the Neurological Sciences

Volumn 212, Issue 1-2, 2003, Pages 1-5

  Uc, Ergun Y ^a,b,c   Skinner, Robert D ^a   Rodnitzky, Robert L ^b   Garcia Rill, Edgar ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Auditory; Evoked potentials; Habituation; Huntington's disease; Reticular formation

Indexed keywords

ADULT; AMPLITUDE MODULATION; ANXIETY; ARTICLE; ATTENTION; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRIC POTENTIAL; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; HUNTINGTON CHOREA; LATENT PERIOD; MALE; PRIORITY JOURNAL; REDUCTION; SLEEP DISORDER; STIMULUS RESPONSE;

EID: 0038120943     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(03)00082-0     Document Type: Article

References (37)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72(6):1993;971-983.
2. Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57(5):1998;369-384.
3. Butters N., Sax D., Montgomery K., Tarlow S. Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Arch. Neurol. 35(9):1978;585-589.
4. Josiassen R.C., Curry L.M., Mancall E.L. Development of neuropsychological deficits in Huntington's disease. Arch. Neurol. 40(13):1983;791-796.
5. Sprengelmeyer R., Lange H., Homberg V. The pattern of attentional deficits in Huntington's disease. Brain. 118(Pt 1):1995;145-152.
6. Paulsen J.S., Ready R.E., Hamilton J.M., Mega M.S., Cummings J.L. Neuropsychiatric aspects of Huntington's disease. J. Neurol. Neurosurg. Psychiatry. 71(3):2001;310-314.
7. Litvan I., Paulsen J.S., Mega M.S., Cummings J.L. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch. Neurol. 55(10):1998;1313-1319.
8. Wiegand M., Moller A.A., Lauer C.J., Stolz S., Schreiber W., Dose M.et al. Nocturnal sleep in Huntington's disease. J. Neurol. 238(4):1991;203-208.
9. Erwin R., Buchwald J.S. Midlatency auditory evoked responses: differential effects of sleep in the human. Electroencephalogr. Clin. Neurophysiol. 65(5):1986;383-392.
10. Erwin R.J., Buchwald J.S. Midlatency auditory evoked responses: differential recovery cycle characteristics. Electroencephalogr. Clin. Neurophysiol. 64(5):1986;417-423.
11. Erwin R.J., Buchwald J.S. Midlatency auditory evoked responses in the human and the cat model. Electroencephalogr. Clin. Neurophysiol. Suppl. 40:1987;461-467.
12. Buchwald J.S., Rubinstein E.H., Schwafel J., Strandburg R.J. Midlatency auditory evoked responses: differential effects of a cholinergic agonist and antagonist. Electroencephalogr. Clin. Neurophysiol. 80(4):1991;303-309.
13. Harrison J.B., Woolf N.J., Buchwald J.S. Cholinergic neurons of the feline pontomesencephalon: I. Essential role in 'Wave A' generation. Brain Res. 520(1-2):1990;43-54.
14. Miyazato H., Skinner R.D., Garcia-Rill E. Neurochemical modulation of the P13 midlatency auditory evoked potential in the rat. Neuroscience. 92(3):1999;911-920.
15. Reese N.B., Garcia-Rill E., Skinner R.D. The pedunculopontine nucleus - auditory input, arousal and pathophysiology. Prog. Neurobiol. 47(2):1995;105-133.
16. Garcia-Rill E. Disorders of the reticular activating system. Med. Hypotheses. 49(5):1997;379-387.
17. Koch M., Kungel M., Herbert H. Cholinergic neurons in the pedunculopontine tegmental nucleus are involved in the mediation of prepulse inhibition of the acoustic startle response in the rat. Exp. Brain Res. 97(1):1993;71-82.
18. Teo C., Rasco L., al Mefty K., Skinner R.D., Boop F.A., Garcia-Rill E. Decreased habituation of midlatency auditory evoked responses in Parkinson's disease. Mov. Disord. 12(5):1997;655-664.
19. Unified Huntington's disease rating scale: reliability and consistency. Mov. Disord. 11(2):1996;136-142.
20. Ehle A.L., Stewart R.M., Lellelid N.A., Leventhal N.A. Evoked potentials in Huntington's disease. A comparative and longitudinal study. Arch. Neurol. 41(4):1984;379-382.
21. Bollen E., Arts R.J., Roos R.A., van der Velde E.A., Buruma O.J. Brainstem reflexes and brainstem auditory evoked responses in Huntington's chorea. J. Neurol. Neurosurg. Psychiatry. 49(3):1986;313-315.
22. Josiassen R.C., Shagass C., Mancall E.L., Roemer R.A. Auditory and visual evoked potentials in Huntington's disease. Electroencephalogr. Clin. Neurophysiol. 57(2):1984;113-118.
23. Goodin D.S., Aminoff M.J. Electrophysiological differences between subtypes of dementia. Brain. 109(Pt 6):1986;1103-1113.
24. Rijckevorsel-Harmant K. P3 after acoustic and somatosensory stimulation in patients with Huntington disease. Neurophysiol. Clin. 22(1):1992;17-25.
25. Rosenberg C., Nudleman K., Starr A. Cognitive evoked potentials (P300) in early Huntington's disease. Arch. Neurol. 42(10):1985;984-987.
26. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J. Neurol. Neurosurg. Psychiatry. 58(2):1995;192-200.
27. Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 51(4):1988;540-543.
28. Pahapill P.A., Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain. 123(Pt 9):2000;1767-1783.
29. Zweig R.M., Jankel W.R., Hedreen J.C., Mayeux R., Price D.L. The pedunculopontine nucleus in Parkinson's disease. Ann. Neurol. 26(1):1989;41-46.
30. Lee M.S., Rinne J.O., Marsden C.D. The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med. J. 41(2):2000;167-184.
31. Zweig R.M., Whitehouse P.J., Casanova M.F., Walker L.C., Jankel W.R., Price D.L. Loss of pedunculopontine neurons in progressive supranuclear palsy. Ann. Neurol. 22(1):1987;18-25.
32. Manaye K.F., Zweig R., Wu D., Hersh L.B., De Lacalle S., Saper C.B.et al. Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain. Neuroscience. 89(3):1999;759-770.
33. Mesulam M.M., Geula C., Bothwell M.A., Hersh L.B. Human reticular formation: cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J. Comp. Neurol. 283(4):1989;611-633.
34. Cullum C.M., Harris J.G., Waldo M.C., Smernoff E., Madison A., Nagamoto H.T.et al. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr. Res. 10(2):1993;131-141.
35. Karper L.P., Freeman G.K., Grillon C., Morgan C.A. III, Charney D.S., Krystal J.H. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. J. Neuropsychiatry Clin. Neurosci. 8(1):1996;60-66.
36. Skinner R.D., Rasco L.M., Fitzgerald J., Karson C.N., Matthew M., Williams D.K.et al. Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder. Depress. Anxiety. 9(3):1999;122-130.
37. Zweig R.M., Ross C.A., Hedreen J.C., Peyser C., Cardillo J.E., Folstein S.E.et al. Locus coeruleus involvement in Huntington's disease. Arch. Neurol. 49(2):1992;152-156.